Instil Bio, Inc. (TIL)
NASDAQ: TIL · IEX Real-Time Price · USD
12.65
+0.03 (0.24%)
At close: Jul 19, 2024, 4:00 PM
12.68
+0.03 (0.24%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Instil Bio Employees
Instil Bio had 49 employees as of December 31, 2023. The number of employees decreased by 143 or -74.48% compared to the previous year.
Employees
49
Change (1Y)
-143
Growth (1Y)
-74.48%
Revenue / Employee
n/a
Profits / Employee
-$2,516,755
Market Cap
82.27M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 49 | -143 | -74.48% |
| Dec 31, 2022 | 192 | -220 | -53.40% |
| Dec 31, 2021 | 412 | 262 | 174.67% |
| Dec 31, 2020 | 150 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Sangamo Therapeutics | 405 |
| CASI Pharmaceuticals | 176 |
| AlloVir | 112 |
| DBV Technologies | 105 |
| Verastem | 73 |
| Chimerix | 72 |
| BioAtla | 65 |
| AN2 Therapeutics | 41 |
TIL News
- 2 months ago - Instil Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 months ago - Instil Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update - GlobeNewsWire
- 6 months ago - Instil Bio Announces Strategic Update - GlobeNewsWire
- 8 months ago - Instil Bio Announces Effective Date of 1-for-20 Reverse Stock Split - GlobeNewsWire
- 8 months ago - Instil Bio Reports Third Quarter 2023 Financial Results and Provides Corporate Update - GlobeNewsWire
- 9 months ago - Instil Bio Announces Poster Presentations of ITIL-306 Preclinical Data at SITC 2023 Annual Meeting - GlobeNewsWire
- 1 year ago - Instil Bio Reports Second Quarter 2023 Financial Results and Provides Corporate Update - GlobeNewsWire
- 1 year ago - Instil Bio Announces Oral Presentation of ITIL-306 Preclinical Data at British Society for Gene and Cell Therapy Annual Conference - GlobeNewsWire